US Stock MarketDetailed Quotes

IGC IGC Pharma

Watchlist
  • 0.3510
  • +0.0120+3.54%
Close Nov 18 16:00 ET
  • 0.3451
  • -0.0059-1.68%
Post 20:01 ET
27.18MMarket Cap-1755P/E (TTM)

IGC Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
Total revenue
41.58%412K
-50.99%272K
47.64%1.35M
77.71%295K
-38.55%204K
44.06%291K
161.79%555K
129.47%911K
36.07%166K
133.80%332K
Operating revenue
41.58%412K
-50.99%272K
47.64%1.35M
77.71%295K
-38.55%204K
44.06%291K
161.79%555K
129.47%911K
36.07%166K
133.80%332K
Cost of revenue
82.91%214K
-63.67%109K
30.49%612K
20.39%124K
-69.13%71K
74.63%117K
328.57%300K
131.03%469K
90.74%103K
187.50%230K
Gross profit
13.79%198K
-36.08%163K
65.84%733K
171.43%171K
30.39%133K
28.89%174K
79.58%255K
127.84%442K
-7.35%63K
64.52%102K
Operating expense
-26.53%1.96M
6.89%2.56M
-12.34%10.53M
-42.93%2.34M
31.55%3.13M
1.60%2.67M
-18.68%2.39M
-23.10%12.01M
-37.56%4.1M
-2.74%2.38M
Selling and administrative expenses
-25.48%1.04M
1.40%1.67M
-20.98%6.76M
-58.83%1.49M
41.55%2.23M
-24.69%1.4M
6.26%1.65M
-35.66%8.55M
-32.37%3.61M
-23.96%1.57M
Research and development costs
-27.68%917K
19.01%889K
9.01%3.77M
73.43%855K
12.03%903K
65.10%1.27M
-46.41%747K
48.54%3.46M
-60.02%493K
113.79%806K
Operating profit
29.35%-1.76M
-12.01%-2.4M
15.32%-9.8M
46.27%-2.17M
-31.61%-3M
-0.12%-2.49M
23.66%-2.14M
25.00%-11.57M
37.87%-4.04M
4.49%-2.28M
Net non-operating interest income expense
Other net income (expense)
7.50%43K
-71.88%18K
-5,026.15%-3.2M
-8,044.44%-715K
-9,034.48%-2.59M
-13.04%40K
276.47%64K
-84.22%65K
550.00%9K
625.00%29K
Special income (charges)
----
----
---3.35M
---722K
---2.62M
----
----
--0
--0
--0
-Less:Impairment of capital assets
----
----
--3.35M
--722K
--2.62M
----
----
--0
--0
--0
Other non- operating income (expenses)
7.50%43K
-71.88%18K
120.00%143K
-22.22%7K
10.34%32K
-13.04%40K
276.47%64K
-85.90%65K
-10.00%9K
625.00%29K
Income before tax
29.95%-1.72M
-14.60%-2.38M
-12.98%-13M
28.41%-2.89M
-148.51%-5.59M
-0.37%-2.45M
25.49%-2.08M
23.38%-11.51M
38.03%-4.03M
5.54%-2.25M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
29.95%-1.72M
-14.60%-2.38M
-12.98%-13M
28.41%-2.89M
-148.51%-5.59M
-0.37%-2.45M
25.49%-2.08M
23.38%-11.51M
38.03%-4.03M
5.54%-2.25M
Net income continuous Operations
29.95%-1.72M
-14.60%-2.38M
-12.98%-13M
28.41%-2.89M
-148.51%-5.59M
-0.37%-2.45M
25.49%-2.08M
23.38%-11.51M
38.03%-4.03M
5.54%-2.25M
Minority interest income
Net income attributable to the parent company
29.95%-1.72M
-14.60%-2.38M
-12.98%-13M
28.41%-2.89M
-148.51%-5.59M
-0.37%-2.45M
25.49%-2.08M
23.38%-11.51M
38.03%-4.03M
5.54%-2.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
29.95%-1.72M
-14.60%-2.38M
-12.98%-13M
28.41%-2.89M
-148.51%-5.59M
-0.37%-2.45M
25.49%-2.08M
23.38%-11.51M
38.03%-4.03M
5.54%-2.25M
Basic earnings per share
60.00%-0.02
25.00%-0.03
0.00%-0.22
50.00%-0.04
-125.00%-0.09
0.00%-0.05
20.00%-0.04
26.67%-0.22
33.33%-0.08
20.00%-0.04
Diluted earnings per share
60.00%-0.02
25.00%-0.03
0.00%-0.22
50.00%-0.04
-125.00%-0.09
0.00%-0.05
20.00%-0.04
26.67%-0.22
33.33%-0.08
20.00%-0.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022
Total revenue 41.58%412K-50.99%272K47.64%1.35M77.71%295K-38.55%204K44.06%291K161.79%555K129.47%911K36.07%166K133.80%332K
Operating revenue 41.58%412K-50.99%272K47.64%1.35M77.71%295K-38.55%204K44.06%291K161.79%555K129.47%911K36.07%166K133.80%332K
Cost of revenue 82.91%214K-63.67%109K30.49%612K20.39%124K-69.13%71K74.63%117K328.57%300K131.03%469K90.74%103K187.50%230K
Gross profit 13.79%198K-36.08%163K65.84%733K171.43%171K30.39%133K28.89%174K79.58%255K127.84%442K-7.35%63K64.52%102K
Operating expense -26.53%1.96M6.89%2.56M-12.34%10.53M-42.93%2.34M31.55%3.13M1.60%2.67M-18.68%2.39M-23.10%12.01M-37.56%4.1M-2.74%2.38M
Selling and administrative expenses -25.48%1.04M1.40%1.67M-20.98%6.76M-58.83%1.49M41.55%2.23M-24.69%1.4M6.26%1.65M-35.66%8.55M-32.37%3.61M-23.96%1.57M
Research and development costs -27.68%917K19.01%889K9.01%3.77M73.43%855K12.03%903K65.10%1.27M-46.41%747K48.54%3.46M-60.02%493K113.79%806K
Operating profit 29.35%-1.76M-12.01%-2.4M15.32%-9.8M46.27%-2.17M-31.61%-3M-0.12%-2.49M23.66%-2.14M25.00%-11.57M37.87%-4.04M4.49%-2.28M
Net non-operating interest income expense
Other net income (expense) 7.50%43K-71.88%18K-5,026.15%-3.2M-8,044.44%-715K-9,034.48%-2.59M-13.04%40K276.47%64K-84.22%65K550.00%9K625.00%29K
Special income (charges) -----------3.35M---722K---2.62M----------0--0--0
-Less:Impairment of capital assets ----------3.35M--722K--2.62M----------0--0--0
Other non- operating income (expenses) 7.50%43K-71.88%18K120.00%143K-22.22%7K10.34%32K-13.04%40K276.47%64K-85.90%65K-10.00%9K625.00%29K
Income before tax 29.95%-1.72M-14.60%-2.38M-12.98%-13M28.41%-2.89M-148.51%-5.59M-0.37%-2.45M25.49%-2.08M23.38%-11.51M38.03%-4.03M5.54%-2.25M
Income tax 0000000000
Net income 29.95%-1.72M-14.60%-2.38M-12.98%-13M28.41%-2.89M-148.51%-5.59M-0.37%-2.45M25.49%-2.08M23.38%-11.51M38.03%-4.03M5.54%-2.25M
Net income continuous Operations 29.95%-1.72M-14.60%-2.38M-12.98%-13M28.41%-2.89M-148.51%-5.59M-0.37%-2.45M25.49%-2.08M23.38%-11.51M38.03%-4.03M5.54%-2.25M
Minority interest income
Net income attributable to the parent company 29.95%-1.72M-14.60%-2.38M-12.98%-13M28.41%-2.89M-148.51%-5.59M-0.37%-2.45M25.49%-2.08M23.38%-11.51M38.03%-4.03M5.54%-2.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 29.95%-1.72M-14.60%-2.38M-12.98%-13M28.41%-2.89M-148.51%-5.59M-0.37%-2.45M25.49%-2.08M23.38%-11.51M38.03%-4.03M5.54%-2.25M
Basic earnings per share 60.00%-0.0225.00%-0.030.00%-0.2250.00%-0.04-125.00%-0.090.00%-0.0520.00%-0.0426.67%-0.2233.33%-0.0820.00%-0.04
Diluted earnings per share 60.00%-0.0225.00%-0.030.00%-0.2250.00%-0.04-125.00%-0.090.00%-0.0520.00%-0.0426.67%-0.2233.33%-0.0820.00%-0.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data